• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR GRAFTMASTER RX CORONARY STENT GRAFT SYSTEM; CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR GRAFTMASTER RX CORONARY STENT GRAFT SYSTEM; CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1012580-16
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Angina (1710); Cardiac Arrest (1762); Myocardial Infarction (1969); Tachycardia (2095); Thrombosis/Thrombus (4440)
Event Date 07/15/2023
Event Type  Injury  
Event Description
It was reported that the procedure was performed to treat a lesion in the mid left anterior descending coronary artery (mlad).After an instantaneous wave-free ratio (ifr) was performed to confirm the lesion area, a 2.5x22mm non-abbott stent was used to treat the lesion; however, a perforation was noted in the left ventricle.A balloon angioplasty was performed with a 2.5x20mm unspecified balloon for seven minutes, but it did not work; therefore, a 2.8x16mm graftmaster was used at 18 atmospheres in the middle of the previous stent to seal the perforation and the patient developed chest pain.An electrocardiogram (ekg) confirmed st elevations without evidence of pericardial effusion which was treated with medication.The patient was hospitalized, and was being monitored; however, the chest pain continued and the patient experienced ventricular tachycardia and cardiac arrest; therefore, cardiopulmonary resuscitation (cpr) was performed.An angiography was performed, which confirmed that the stent was thrombosed.A clot was removed with a non-abbott device and an intravascular ultrasound (ivus) was performed after the clot was removed.The patient is doing well.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue.It was reported that the graftmaster was deployed with a maximum pressure of 18 atmospheres (atm).It should be noted in the graftmaster rapid exchange (rx), coronary stent graft system, domestic, instructions for use (ifu) specifies the rated burst pressure (rbp) is 16 atm and clearly states not to exceed the rbp.In this case, it is unknown if the ifu deviation contributed to the reported event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatments appear to be related to the operational context of the procedure.The reported patient effects of tachycardia, myocardial infarction and thrombosis are listed in the graftmaster rx coronary stent graft system, instructions for use (ifu) as known patient effects that may be associated with use of a coronary stent in native coronary arteries.There is no indication of a product quality issue with respect to manufacture, design, or labeling.H6- device code 2017 clarifier: above rbpna.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAFTMASTER RX CORONARY STENT GRAFT SYSTEM
Type of Device
CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17484369
MDR Text Key320659299
Report Number2024168-2023-08544
Device Sequence Number1
Product Code MAF
UDI-Device Identifier08717648176340
UDI-Public08717648176340
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H000001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1012580-16
Device Lot Number2062041
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Disability; Hospitalization;
Patient Age68 YR
Patient SexFemale
Patient Weight66 KG
-
-